Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kura Oncology

8.50
+0.15001.80%
Volume:94.71K
Turnover:803.54K
Market Cap:737.78M
PE:-3.76
High:8.58
Open:8.43
Low:8.43
Close:8.35
52wk High:21.40
52wk Low:5.41
Shares:86.80M
Float Shares:63.99M
Volume Ratio:0.71
T/O Rate:0.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2592
EPS(LYR):-2.0193
ROE:-51.11%
ROA:-22.93%
PB:2.42
PE(LYR):-4.21

Loading ...

Wedbush Keeps Their Buy Rating on Kura Oncology (KURA)

TIPRANKS
·
1 hour ago

Promising Developments in Kura Oncology’s FTI Programs Highlighted by Analyst Buy Rating

TIPRANKS
·
3 hours ago

Kura Oncology Highlights Preclinical Data Demonstrating Potential of Farnesyl Transferase Inhibitors to Overcome Drug Resistance in Combination with Key Targeted Therapies Across Multiple Tumor Types

GlobeNewswire
·
17 hours ago

Troy E. Wilson, President & CEO of Kura Oncology Inc., Reports Acquisition of Common Shares

Reuters
·
Sep 10

Kura Oncology Initiated at Neutral by Guggenheim

Dow Jones
·
Sep 04

Kura Oncology Announces First Clinical Data from Next-Generation Farnesyl Transferase Inhibitor KO-2806 at ESMO Congress 2025

Reuters
·
Sep 03

Kura Oncology Inc. to Participate in Cantor Global Health Conference

Reuters
·
Aug 28

Sector Update: Health Care Stocks Climb Late Afternoon

MT Newswires Live
·
Aug 16

Kura Oncology Shares Rise After CEO Buys Company Shares

MT Newswires Live
·
Aug 16

Kura Oncology Up Over 13%, on Pace for Largest Percent Increase Since January 2024 -- Data Talk

Dow Jones
·
Aug 15

Stock Track | Kura Oncology Soars 5.45% as CEO Makes Significant Stock Purchase

Stock Track
·
Aug 15

Troy E. Wilson, President and CEO of Kura Oncology Inc., Reports Acquisition of Common Shares

Reuters
·
Aug 15

Stock Track | Kura Oncology Plummets 5.70% Pre-Market on Disappointing Q2 Earnings

Stock Track
·
Aug 08

Stock Track | Kura Oncology Plummets 5.70% in Pre-Market Following Disappointing Q2 Earnings Report

Stock Track
·
Aug 08

Kura Oncology Q2 EPS $(0.75) Misses $(0.43) Estimate, Sales $15.288M Miss $36.664M Estimate

Benzinga
·
Aug 08

Kura Oncology Q2 EPS USD -0.75

THOMSON REUTERS
·
Aug 08

Kura Oncology Reports Second Quarter 2025 Financial Results

GlobeNewswire
·
Aug 08

BRIEF-Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule

Reuters
·
Aug 04

Kura Oncology Announces Inducement Stock Option Grants for New Employees Under 2023 Plan

Reuters
·
Aug 04

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 04